SLN

← Markets

SLNSilence Therapeutics Plc - American Depository Share

Discussion

Nothing said here yet.

to join the conversation.

—

Fri, Aug 14
3:55 PMYahooSilence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
Thu, Aug 13
8:55 AMYahooWall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know
Tue, Aug 11
10:20 PMYahooSilence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
12:01 AMmarketbeat.comSilence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
Mon, Aug 10
3:01 PMYahooSilence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
6:30 AMYahooSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
6:15 AMYahooSilence Therapeutics Reports Second Quarter 2026 Financial and Business Results
Sun, Aug 9
4:00 PMYahooSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
Tue, Jun 30
8:06 AMYahooSilence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential
Thu, Jun 25
6:48 AMYahooSilence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?
Wed, Jun 17
10:16 AMYahooHow Silence Therapeutics (SLN) Is Building the Divesiran Case Around Fewer Blood Draws in Polycythemia Vera
Thu, Jun 11
6:30 AMYahooSilence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera